Translating the Why WAIT Toolkit for Primary Care Practie

描述(由申请人提供)：翻译初级保健实践为什么等待工具包将调整为什么等待计划的行为干预部分，并评估在初级保健实践中实施它的可行性。主要目标是将当前非常成功的为什么等待计划的一个组成部分转化为可以广泛传播到初级保健环境的模式，在初级保健环境中，超过85%的糖尿病患者在美国接受医疗保健，并评估在该环境中实施调整后的计划的可行性。具体目标是：目标1计划调整：将成功的为什么等待计划的行为治疗部分转化为初级保健实践(PCP)，为患者和提供者提供适当的交付方法和信息。目的2可行性评估：通过项目评估和对提供者和患者的定性研究，评估在初级保健环境中实施适应的组成部分的可行性。目的3全面评估的随机试验设计：最终确定随机对照试验的研究设计，并为完全适应的为什么等待计划的随机对照试验招募足够的初级保健实习地点。在成功完成建议的目标后，我们将能够适应整个计划，并使用严格的群组随机试验进行全面测试，该试验最大限度地扩大普适性并最大限度地减少偏见。人与人之间的联系与基于媒体的支持的创新结合将产生一个为什么要等待的计划，该计划将在已知的时间和资源限制下运行，对PCP非常有用。与PCP和糖尿病患者的定性深入讨论，将为翻译为什么等待节目提供信息，以解决这些受众面临的需求和障碍。这将产生一个被PCP有效利用的计划，以覆盖更大比例的糖尿病人口，并将通过减轻体重和管理糖尿病对公共健康产生更大的影响，而不是设在专门诊所的计划。这一努力的最终结果将增加向患者提供管理其疾病的工具的机会，从而减少T2 DM的死亡率和发病率后果。

DESCRIPTION (provided by applicant): Translating the Why WAIT Toolkit for Primary Care Practice will adapt the behavioral intervention component of the Why WAIT program and evaluate the feasibility of implementing it in primary care practices. The primary goal is to translate one component of the current and highly successful Why WAIT program into a model that can be widely disseminated to the primary care setting, where more than 85% of patients with diabetes receive their health care in the US and to evaluate the feasibility of implementing the adapted program in that setting. The specific aims are: Aim 1 Program Adaptation: Translate the behavioral therapy component of the successful Why WAIT program to primary care practices (PCP) with appropriate delivery approaches and messaging for both patients and providers. Aim 2 Feasibility assessment: Evaluate the feasibility of implementing the adapted component in primary care setting through program evaluation and qualitative research with providers and patients. Aim 3 Design of randomized trial for full scale evaluation: Finalize study design of the randomized controlled trial and recruit sufficient primary care practice sites for a randomized controlled trial of the fully adapted Why WAIT program Upon successful completion of the proposed objectives, we will be in a position adapt the entire program and to fully test it using a rigorous cluster randomized trial that maximizes generalizabity and minimizes bias. The innovative combination of interpersonal contact with media based support will result in a Why WAIT program that will be a extremely useful for PCPs, operating within known constraints, such as time and resources. The qualitative in-depth discussion with PCPs and diabetes patients, will inform the translation of the Why WAIT program to address the needs and obstacles faced by this audience. This will result in a program that will be used effectively by PCPs to reach a larger proportion of the diabetes population and will have a greater Public Health impact through weight reduction and diabetes management than programs located in specialty clinics. The final result of this effort will increase the opportunities to provide the tools to patients to manage their disease and thereby to reduce the mortality and morbidity consequences of T2DM.